Clinical value of cholinesterase in the prediction of biochemical recurrence after radical prostatectomy
- 1 December 2018
- journal article
- research article
- Published by Elsevier in Urologic Oncology: Seminars and Original Investigations
- Vol. 36 (12) , 528.e7-528.e13
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Cholinesterase activities and biochemical determinations in patients with prostate cancer: Influence of Gleason score, treatment and bone metastasisBiomedicine & Pharmacotherapy, 2012
- Cancer-Specific and Other-Cause Mortality After Radical Prostatectomy Versus Observation in Patients with Prostate Cancer: Competing-Risks Analysis of a Large North American Population-Based CohortEuropean Urology, 2011
- Predictive and Prognostic Models in Radical Prostatectomy Candidates: A Critical Analysis of the LiteratureEuropean Urology, 2010
- Clinicians are poor raters of life‐expectancy before radical prostatectomy or definitive radiotherapy for localized prostate cancerBJU International, 2007
- Caveolin‐1 overexpression is associated with aggressive prostate cancer recurrenceThe Prostate, 2007
- Defining Biochemical Recurrence of Prostate Cancer After Radical Prostatectomy: A Proposal for a Standardized DefinitionJournal of Clinical Oncology, 2006
- Expression of cholinesterases in brain and non-brain tumoursChemico-Biological Interactions, 2005
- Pesticides and Lung Cancer Risk in the Agricultural Health Study CohortAmerican Journal of Epidemiology, 2004
- Association of Preoperative Plasma Levels of Vascular Endothelial Growth Factor and Soluble Vascular Cell Adhesion Molecule-1 With Lymph Node Status and Biochemical Progression After Radical ProstatectomyJournal of Clinical Oncology, 2004
- Lymphovascular Invasion is a Pathological Feature of Biologically Aggressive Disease in Patients Treated With Radical ProstatectomyJournal of Urology, 2004